Skip to main content
GF

General Fluidics

General Fluidics develops the Axess™ point-of-care testing platform, which integrates hematology, clinical chemistry, and immunoassay technologies into a single low-cost cartridge for blood diagnostics. This solution addresses the need for accessible, high-quality testing by streamlining workflows and minimizing pre-analytical errors in clinical settings.

Waltham, United StatesFounded 2014131K+ followers
Updated 4 months ago

Funding

$18.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional blood diagnostic testing often requires sending samples to centralized laboratories, leading to delays in obtaining results and hindering timely clinical decision-making, especially in point-of-care settings. Existing point-of-care solutions may lack the comprehensive test menus and accuracy of reference laboratories.

Solution

General Fluidics offers the Axess™ point-of-care testing platform, designed to bring reference laboratory-quality blood diagnostics directly to the patient's side. The Axess™ platform integrates hematology, clinical chemistry, and immunoassay technologies into a single, low-cost cartridge, enabling a comprehensive test menu at the point of care. This streamlined, end-to-end solution simplifies the testing workflow from sample collection to result delivery, reducing the burden on clinical staff and minimizing pre-analytical errors. The platform's hybrid hardware architecture and programmable cartridge facilitate flexible testing options, accommodating standard, consolidated, and custom test panels.

Target Audience

The primary target audience includes healthcare providers, hospitals, and clinics seeking to improve patient care through faster, more accessible, and higher-quality point-of-care blood diagnostics.

Features

  • Integrates hematology, clinical chemistry, and immunoassay technologies on a single platform
  • Utilizes a low-cost, programmable cartridge for flexible test menu options
  • Streamlines testing workflow from sample collection to result delivery
  • Employs the same analytical and reagent technology used by reference laboratory equipment
  • Minimizes staff burden and operator error through an end-to-end solution
This profile is AI-generated and may contain inaccuracies.